gatifloxacin has been researched along with Eye Infections, Fungal in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Eye Infections, Fungal: Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin showed lower resistance levels than moxifloxacin." | 1.38 | [In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Bispo, PJM | 1 |
| Tanner, EEL | 1 |
| Mitragotri, S | 1 |
| E Silva, RN | 1 |
| Gipson, I | 1 |
| Chodosh, J | 1 |
| Behlau, I | 1 |
| Paschalis, EI | 1 |
| Gilmore, MS | 1 |
| Dohlman, CH | 1 |
| Ohtomo, K | 1 |
| Ueta, T | 1 |
| Nagahara, M | 1 |
| Wong, CA | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Villareal, D | 1 |
| Rey, JJ | 1 |
| Ozdek, SC | 1 |
| Miller, D | 1 |
| Flynn, PM | 1 |
| Flynn, HW | 1 |
4 other studies available for gatifloxacin and Eye Infections, Fungal
| Article | Year |
|---|---|
The Search for Antifungal Prophylaxis After Artificial Corneal Surgery-An In Vitro Study.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillus fumigatus; Benzalkonium Compounds; C | 2020 |
Congenital nasolacrimal duct obstruction with fungal dacryoliths.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspergillosis; Drug Therapy, Combina | 2015 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; | 2012 |
In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.
Topics: Anti-Infective Agents; Aza Compounds; Candida; Colony Count, Microbial; Eye Infections, Fungal; Fluo | 2006 |